Back to results
US 2025/0164505 A1Published application
Detection of extracellular vesicle biomarkers for the diagnosis of autism spectrum disorder
AssigneeQatar Foundation for Education, Science and Community Development
InventorsYongsoo Park, Sara Abdulla
Life of this patent
Estimating the term…
Abstract
Methods for early diagnosis of autism spectrum disorder, based on detecting certain protein biomarkers associated with plasma extracellular vesicles, are described.
Claims15
A method for diagnosing autism spectrum disorder comprising
- a) isolating extracellular vesicles (EVs) from plasma samples of subjects suffering from autism spectrum disorder;
- and
- b) measuring protein expression levels in the extracellular vesicles.
A method for diagnosing autism spectrum disorder comprising:
- a) isolating extracellular vesicles (EVs) from plasma samples of subjects suffering from autism spectrum disorder;
- b) lysing or permeabilizing the EVs;
- and
- c) measuring expression levels of proteins selected from WWP2, CLEC1B, HSP-27, CD40, and/or FR-alpha using an enzyme-linked immunosorbent assay (ELISA);
- wherein increased expression of proteins selected from WWP2, CLEC1B, HSP-27, CD40, and/or FR-alpha compared to control is diagnostic of autism spectrum disorder.
2 more elements
A method for diagnosing autism spectrum disorder comprising:
- a) isolating extracellular vesicles (EVs) from plasma samples of subjects suffering from autism spectrum disorder;
- b) lysing or permeabilizing the EVs;
- and
- c) measuring expression levels of proteins selected from Gro-alpha, INF-gamma, IL-15, RANTES, SCGF-beta, and/or VEGF, using an enzyme-linked immunosorbent assay (ELISA);
- wherein abnormal expression of proteins selected from Gro-alpha, INF-gamma, IL-15, RANTES, SCGF-beta, and/or VEGF compared to control, is diagnostic of autism spectrum disorder.
2 more elements
Dependencies are inferred from the claim text.